乳腺癌患者放射性皮炎的预防和管理循证摘要

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-07-14 DOI:10.1016/j.apjon.2024.100556

Xiaocen Chen , Xueyu Li , Zhao Wang , Ruishuang Zheng , Fang Zhang , Jing Zhao , Huiying Liu , Hongyuan Luo

{"title":"乳腺癌患者放射性皮炎的预防和管理循证摘要","authors":"Xiaocen Chen , Xueyu Li , Zhao Wang , Ruishuang Zheng , Fang Zhang , Jing Zhao , Huiying Liu , Hongyuan Luo","doi":"10.1016/j.apjon.2024.100556","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Up to now there is a lack of research to summarize the relevant evidence for radiation dermatitis (RD) management in patients with breast cancer. Therefore, this study aimed to summarize the best evidence for the prevention and management of RD in patients with breast cancer.</p></div><div><h3>Methods</h3><p>According to the “6S” evidence pyramid model, all major databases were searched from January 2018 to February 2024: UpToDate, BMJ Best Practice, National Guideline Clearinghouse, Guidelines International Network, MedSci, Yi Maitong Guidelines, National Comprehensive Cancer Network, Oncology Nursing Society, Radiology Assistant database, Society and College of Radiographers, Australian JBI Evidence-Based Health Care Center database, Cochrane Library, PubMed, CINAHL, Embase, Web of Science, China National Knowledge Infrastructure, Wangfang Data, Chinese Science and Technology Journal Database, Chinese Biology Medicine, etc.</p></div><div><h3>Results</h3><p>A total of 22 articles which met the inclusion criteria were included in the study, comprising six guidelines, nine systematic reviews, four evidence summaries, one clinical decision, one expert consensus, and one randomized controlled trial. We summarized 35 pieces of evidence across four aspects: influence factor, evaluation and monitoring, prevention and treatment, care and health education.</p></div><div><h3>Conclusions</h3><p>This study provides a comprehensive summary of the best evidence for the prevention and management of RD in patients with breast cancer. It is recommended that subsequent evidence transformation should be conducted based on specific clinical circumstances to standardize the process of clinical prevention and management of RD.</p></div><div><h3>Systematic review registration</h3><p>This study was registered at the Fudan University Center for Evidence-Based Nursing (Registration No. ES20244311).</p></div>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001781/pdfft?md5=23f544d83ff5da85f169acece657b5c0&pid=1-s2.0-S2347562524001781-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Evidence-based summary of the prevention and management of radiation dermatitis in patients with breast cancer\",\"authors\":\"Xiaocen Chen , Xueyu Li , Zhao Wang , Ruishuang Zheng , Fang Zhang , Jing Zhao , Huiying Liu , Hongyuan Luo\",\"doi\":\"10.1016/j.apjon.2024.100556\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>Up to now there is a lack of research to summarize the relevant evidence for radiation dermatitis (RD) management in patients with breast cancer. Therefore, this study aimed to summarize the best evidence for the prevention and management of RD in patients with breast cancer.</p></div><div><h3>Methods</h3><p>According to the “6S” evidence pyramid model, all major databases were searched from January 2018 to February 2024: UpToDate, BMJ Best Practice, National Guideline Clearinghouse, Guidelines International Network, MedSci, Yi Maitong Guidelines, National Comprehensive Cancer Network, Oncology Nursing Society, Radiology Assistant database, Society and College of Radiographers, Australian JBI Evidence-Based Health Care Center database, Cochrane Library, PubMed, CINAHL, Embase, Web of Science, China National Knowledge Infrastructure, Wangfang Data, Chinese Science and Technology Journal Database, Chinese Biology Medicine, etc.</p></div><div><h3>Results</h3><p>A total of 22 articles which met the inclusion criteria were included in the study, comprising six guidelines, nine systematic reviews, four evidence summaries, one clinical decision, one expert consensus, and one randomized controlled trial. We summarized 35 pieces of evidence across four aspects: influence factor, evaluation and monitoring, prevention and treatment, care and health education.</p></div><div><h3>Conclusions</h3><p>This study provides a comprehensive summary of the best evidence for the prevention and management of RD in patients with breast cancer. It is recommended that subsequent evidence transformation should be conducted based on specific clinical circumstances to standardize the process of clinical prevention and management of RD.</p></div><div><h3>Systematic review registration</h3><p>This study was registered at the Fudan University Center for Evidence-Based Nursing (Registration No. ES20244311).</p></div>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2347562524001781/pdfft?md5=23f544d83ff5da85f169acece657b5c0&pid=1-s2.0-S2347562524001781-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2347562524001781\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2347562524001781","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}

引用次数: 0

摘要

目的迄今为止，尚缺乏对乳腺癌患者放射性皮炎（RD）管理相关证据进行总结的研究。因此，本研究旨在总结乳腺癌患者 RD 预防和管理的最佳证据。方法根据 "6S "证据金字塔模型，检索了 2018 年 1 月至 2024 年 2 月的所有主要数据库：UpToDate、BMJ Best Practice、美国国家指南交换中心、指南国际网络、MedSci、易麦通指南、美国国家综合癌症网络、肿瘤护理学会、放射学助理数据库、放射技师学会和学院、澳大利亚JBI循证医疗中心数据库、Cochrane图书馆、PubMed、CINAHL、Embase、Web of Science、中国国家知识基础设施、万方数据、中文科技期刊数据库、中国生物医学等。结果本研究共纳入符合纳入标准的 22 篇文章，包括 6 篇指南、9 篇系统综述、4 篇证据摘要、1 篇临床决策、1 篇专家共识和 1 篇随机对照试验。我们从影响因素、评估和监测、预防和治疗、护理和健康教育四个方面总结了 35 项证据。结论本研究全面总结了乳腺癌患者 RD 预防和管理的最佳证据。系统综述注册本研究已在复旦大学循证护理研究中心注册（注册号：ES20244311）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Evidence-based summary of the prevention and management of radiation dermatitis in patients with breast cancer

Objective

Up to now there is a lack of research to summarize the relevant evidence for radiation dermatitis (RD) management in patients with breast cancer. Therefore, this study aimed to summarize the best evidence for the prevention and management of RD in patients with breast cancer.

Methods

According to the “6S” evidence pyramid model, all major databases were searched from January 2018 to February 2024: UpToDate, BMJ Best Practice, National Guideline Clearinghouse, Guidelines International Network, MedSci, Yi Maitong Guidelines, National Comprehensive Cancer Network, Oncology Nursing Society, Radiology Assistant database, Society and College of Radiographers, Australian JBI Evidence-Based Health Care Center database, Cochrane Library, PubMed, CINAHL, Embase, Web of Science, China National Knowledge Infrastructure, Wangfang Data, Chinese Science and Technology Journal Database, Chinese Biology Medicine, etc.

Results

A total of 22 articles which met the inclusion criteria were included in the study, comprising six guidelines, nine systematic reviews, four evidence summaries, one clinical decision, one expert consensus, and one randomized controlled trial. We summarized 35 pieces of evidence across four aspects: influence factor, evaluation and monitoring, prevention and treatment, care and health education.

Conclusions

This study provides a comprehensive summary of the best evidence for the prevention and management of RD in patients with breast cancer. It is recommended that subsequent evidence transformation should be conducted based on specific clinical circumstances to standardize the process of clinical prevention and management of RD.